Expected US Company Earnings on Monday, April 14th, 2025

Stock Information for Redhill Biopharma Ltd.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Redhill Biopharma Ltd.

Leading Independent Proxy Advisory ISS Supports Compelling Case for Change to AstroNova Board of Directors and Recommends Vote on the GOLD Askeladden Card
AstroNova Made Good Faith Effort to Resolve Costly, Disruptive Proxy Contest in Collaborative and Amicable Manner
AstroNova's Board Stonewalls Meaningful Change
AstroNova Letter to Shareholders Highlights Board's Commitment to Shareholder Value
AstroNova Sends Letter to Shareholders: Board Focused on Driving Accountability
AstroNova Announces Segment Leadership Promotions to Drive Execution of Growth Strategy
AstroNova Reports First-Quarter Fiscal 2026 Revenue Grew 14% Driven by Double Digit Growth in Both Aerospace and Product Identification Segments
AstroNova to Report First Quarter Fiscal Year 2026 Financial Results on Thursday, June 5

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.